Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Forestier-Certonciny Syndrome

fluorodeoxyglucose f18 has been researched along with Forestier-Certonciny Syndrome in 70 studies

Research

Studies (70)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.43)	18.2507
2000's	12 (17.14)	29.6817
2010's	33 (47.14)	24.3611
2020's	24 (34.29)	2.80

Authors

Authors	Studies
Camacho Marti, V; Castellví, I; Corica, ME; Corominas, H; Fernandez Leon, A; López-Mora, DA; Moya-Alvarado, P	1
Holzinger, J; Lakomek, HJ; Reinbold, WD; Witte, F	1
Al Khayyat, SG; Baldi, C; Bardelli, M; Cantarini, L; Conticini, E; D'Alessandro, R; Falsetti, P; Frediani, B; Gentileschi, S	1
Giraud, N; Prati, C; Verhoeven, F; Wendling, D	2
Besson, FL; Nocturne, G; Pean De Ponfilly-Sotier, M; Seror, R	1
Allegri, V; Fanti, S; Lanzafame, H; Mulè, R; Zanoni, L	1
Akiyama, M; Hama, S; Higashida-Konishi, M; Izumi, K; Okano, Y; Oshige, T; Oshima, H; Shimada, T	1
Benali, K; Casadepax-Soulet, C; Crestani, B; Dieudé, P; Ebstein, E; Forien, M; Juge, PA; Mahida, B; Ottaviani, S; Piekarski, E	1
Asmar, A; Mark, PD; Skousen, MK	1
Bui, C; Chen, J; Mansberg, R; Wong, VCK	1
Castañeda, S; González-Gay, MA; Heras-Recuero, E; Vicente-Rabaneda, EF	1
Bauckneht, M; Camellino, D; Cimmino, MA; Cutolo, M; Hysa, E; Iannuzzi, F; Morbelli, S; Sambuceti, G	1
Chen, J; Jiang, W; Liu, X; Shao, X; Sun, S; Wang, Y; Wu, M; Xu, T; Zhang, L	1
Banzo, I; Blanco, R; Calderon-Goercke, M; Castañeda, S; González-Gay, MA; Martínez-Rodríguez, I; Prieto-Peña, D	1
Boulahdour, H; Chouk, M; Giraud, N; Prati, C; Sondag, M; Verhoeven, F; Wendling, D	1
Betrains, A; Blockmans, D	1
Kim, K; Kim, SJ	1
Camellino, D; Dejaco, C; Duftner, C	1
Brouwer, E; Gheysens, O; Glaudemans, AWJM; Jamar, F; Slart, RHJA; Treglia, G; van der Geest, KSM	1
Ariyoshi, T; Kubo, M; Nawata, T; Okuda, S; Wada, Y; Yano, M	1
Ahangarani Farahani, Z; Ellingsen, T; Emamifar, A; Gerke, O; Hermann, AP; Hess, S; Jensen Hansen, IM; Syrak Hansen, P; Thye-Rønn, P	1
Bagnasco, M; Bauckneht, M; Camellino, D; Cimmino, MA; Cutolo, M; Morbelli, SD; Paparo, F; Pesce, G; Sambuceti, G	1
Brouwer, E; Glaudemans, AWJM; Nienhuis, P; Sandovici, M; Slart, RHJA; van der Geest, KSM; van Sleen, Y; Westerdijk, N	1
Keidar, Z; Massalha, S; Palchan Hazan, T	1
Park, J; Sung, DH	1
Fojtik, Z; Kazda, T; Nemec, P; Rehak, Z; Sprlakova-Pukova, A; Vargova, L	1
Kubota, K; Mimori, A; Yamashita, H	1
Andersen, HR; Andreasen, RA; Bang, JC; Chrysidis, S; Emamifar, A; Farahani, ZA; Gerke, O; Gildberg-Mortensen, R; Hansen, IMJ; Hansen, PS; Hermann, AP; Hess, S; Laustrup, H; le Greves, S; Marcussen, N; Olsen, RN; Svendstrup, F; Thye-Rønn, P; Toftegaard, P	1
Laustrup, H; Lund-Petersen, A; Voss, A	1
Buchanan, RRC; Kemp, A; Lam, SKL; Lee, ST; Liew, DFL; McMenamin, CM; Owen, CE; Pathmaraj, K; Poon, AMT; Scott, AM; Yap, LP; Zwar, RB	1
Blockmans, D; Gheysens, O; Goffin, K; Henckaerts, L; Vanderschueren, S	1
Cachin, F; Descamps, L; Mathieu, S; Merlin, C; Olagne, L; Soubrier, M	1
Henderson, RD; Ioannides, ZA; Kubler, P; Langguth, D; Thomas, P	1
Cimmino, MA; Clifford, AH	1
Schett, G; Schönau, V	1
Slart, RHJA	1
Banzo, I; Blanco, R; Calderón-Goercke, M; Calvo-Río, V; Castañeda, S; Corrales, A; González-Gay, MÁ; González-Vela, C; Hernández, JL; Loricera, J; Martínez-Rodríguez, I; Prieto-Peña, D	1
Harada, K; Otsuka, F; Otsuka, Y	1
Brzosko, M; Manzo, C; Milchert, M; Natale, M	1
Blagosklonov, O; Boulahdour, H; Prati, C; Wendling, D	1
Camellino, D; Cimmino, MA; Massollo, M; Paparo, F; Piccardo, A; Puppo, C; Rollandi, GA; Shoushtari Zadeh Naseri, M; Villavecchia, G	1
Kaneko, H; Kano, T; Kubota, K; Mimori, A; Miyata, Y; Morooka, M; Okasaki, M; Takahashi, H; Takahashi, Y; Yamashita, H	1
Ikusaka, M; Shikino, K; Shimada, F	1
Adam, J; Adam, Z; Bortlicek, Z; Fojtik, Z; Koukalova, R; Nemec, P; Rehak, Z; Rehakova, D; Vasina, J; Vavrusova, A	1
Abgral, R; Devauchelle-Pensec, V; Garrigues, F; Gouillou, M; Marhadour, T; Palard-Novello, X; Querellou, S; Salaün, PY; Saraux, A	1
Blagosklonov, O; Boulahdour, H; Guillot, X; Prati, C; Sondag, M; Verhoeven, F; Wendling, D	2
Cammilleri, S; Dignat-George, F; Dubois, C; Guis, S; Mege, D; Mundler, O; Panicot-Dubois, L	1
Hanafusa, T; Komori, T; Kotani, T; Makino, S; Takeuchi, T; Wakura, D; Yoshida, S	1
Buttgereit, F; Dasgupta, B; Dejaco, C; Duftner, C; Matteson, EL	1
Iwamoto, I; Liu, R; Nakagawa, T; Seto, Y; Toriihara, A; Umehara, I; Yoshida, K	1
Ichikawa, Y; Itoh, G; Ozaki, S; Shibata, T	1
Ansquer, C; Durant, C; Hamidou, M; Hervier, B; Masseau, A	1
Hanafusa, T; Hirano-Kuwata, S; Iimori, A; Kanzaki, Y; Komori, T; Kotani, T; Makino, S; Takeuchi, T; Ukimura, A; Wakura, D	1
Agostini, D; Besson, FL; Bienvenu, B; Bouvard, G; Costo, S; Parienti, JJ; Prior, JO	1
Ito, K; Kaneko, H; Kano, T; Kubota, K; Mimoiri, A; Minaminoto, R; Morooka, M; Takahashi, Y; Takashima, H; Yamashita, H	1
Adams, H; Raijmakers, P; Smulders, Y	1
Kaneko, H; Kano, T; Kubota, K; Mimori, A; Minamimoto, R; Morooka, M; Takahashi, Y; Yamashita, H	1
Blockmans, DE	1
Donnemiller, E; Gasser, R; Klauser, A; Moncayo, R; Schirmer, M; Wenger, M	1
Czech, N; Henze, E; Kneba, M; Mehl, C; Moosig, F; Schröder, JO; Zeuner, RA	1
Blockmans, D; Bobbaers, H; de Ceuninck, L; Knockaert, D; Mortelmans, L; Vanderschueren, S	2
Dejaco, C; Duftner, C; Schirmer, M; Wipfler, E	1
Atsumi, T; Hashimoto, T; Horita, T; Kataoka, H; Koike, T; Yasuda, S	1
Cimmino, MA; Parodi, M; Zampogna, G	1
de Paula, WD; Dos Anjos, DA; Dos Anjos, RF; Sobrinho, AB	1
Blockmans, D; Bobbaers, H; Bormans, G; Knockaert, D; Maes, A; Mortelmans, L; Nuyts, J; Stroobants, S	1
Blockmans, D; Maes, A; Mortelmans, L; Stroobants, S	1

Reviews

12 review(s) available for fluorodeoxyglucose f18 and Forestier-Certonciny Syndrome

Article	Year
Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy. Rheumatology international, 2023, Volume: 43, Issue:3 Topics: Aged; Arthralgia; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Pain; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2023
Early large vessel systemic vasculitis in adults. Best practice & research. Clinical rheumatology, 2019, Volume: 33, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Systemic Vasculitis	2019
Use of PET clinics, 2020, Volume: 15, Issue:2 Topics: Cost-Benefit Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2020
Diagnostic performance of F-18 fluorodeoxyglucose PET/computed tomography for diagnosis of polymyalgia rheumatica: a meta-analysis. Nuclear medicine communications, 2020, Volume: 41, Issue:12 Topics: Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2020
New insights into the role of imaging in polymyalgia rheumatica. Rheumatology (Oxford, England), 2021, 03-02, Volume: 60, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Ultrasonography	2021
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
The British journal of radiology, 2017, Volume: 90, Issue:1076 Topics: Fluorodeoxyglucose F18; Hip Joint; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Shoulder Joint; Sternoclavicular Joint	2017
Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis. Seminars in nuclear medicine, 2017, Volume: 47, Issue:4 Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Polychondritis, Relapsing; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2017
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:7 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Public Opinion	2018
Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. BioMed research international, 2014, Volume: 2014 Topics: Aorta, Thoracic; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiography; Vasculitis	2014
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford, England), 2017, 04-01, Volume: 56, Issue:4 Topics: Aged; Cytokines; Dendritic Cells; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; T-Lymphocytes	2017
Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:9 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography	2011

Trials

4 trial(s) available for fluorodeoxyglucose f18 and Forestier-Certonciny Syndrome

Article	Year
Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients. Joint bone spine, 2020, Volume: 87, Issue:3 Topics: Aged; Fluorodeoxyglucose F18; Humans; Muscles; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Retrospective Studies; Spine	2020
Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol. Medicine, 2017, Volume: 96, Issue:26 Topics: Biopsy; Denmark; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms; Osteoporosis; Patient Selection; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisolone; Prevalence; Radiopharmaceuticals; Single-Blind Method; Steroids; Temporal Arteries; Vasculitis	2017
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis and rheumatism, 2006, Feb-15, Volume: 55, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methylprednisolone; Polymyalgia Rheumatica; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Risk; Shoulder Joint; Treatment Outcome	2006
New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford, England), 1999, Volume: 38, Issue:5 Topics: Aged; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Radiopharmaceuticals; Subclavian Artery; Tomography, Emission-Computed	1999

Other Studies

54 other study(ies) available for fluorodeoxyglucose f18 and Forestier-Certonciny Syndrome

Article	Year
"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica". PloS one, 2021, Volume: 16, Issue:9 Topics: Aged; Cross-Sectional Studies; Drug Resistance; Female; Fluorodeoxyglucose F18; Humans; Male; Polymyalgia Rheumatica; Radiopharmaceuticals; Retrospective Studies; Steroids	2021
[Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis]. Zeitschrift fur Rheumatologie, 2023, Volume: 82, Issue:2 Topics: Arthritis, Rheumatoid; Electrons; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2023
Polymyalgia Rheumatica: A syndrome with an enthesitic subset? Comment on: "Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice" by Marie Pean de Ponfilly-Sotier et al. Joint Bone Spine 2021;89:10 Joint bone spine, 2022, Volume: 89, Issue:5 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Spondylarthritis	2022
On the use of Joint bone spine, 2022, Volume: 89, Issue:5 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Spondylarthritis	2022
Answer to Giraud et al. "On the use of 18F FDG PET-CT in spondyloarthritis." Joint Bone Spine 2022;89:105377 and to Falsetti et al. "Polymyalgia Rheumatica: a syndrome with an enthesitic subset?" Joint Bone Spine 2022;89:105378. Joint bone spine, 2022, Volume: 89, Issue:5 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Spondylarthritis; Syndrome	2022
A Peculiar 18 F-FDG Spinal Uptake Helps Diagnosis and Effective Treatment of Polymyalgia Rheumatica : "The Corset Sign". Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8 Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2022
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study. Clinical and experimental rheumatology, 2023, Volume: 41, Issue:7 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2023
Ugeskrift for laeger, 2023, Feb-06, Volume: 185, Issue:6 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
FDG PET/CT Imaging of Severe Polymyalgia Rheumatica. Clinical nuclear medicine, 2023, Jul-01, Volume: 48, Issue:7 Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis? Clinical and experimental rheumatology, 2023, Volume: 41, Issue:4 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica	2023
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin. Clinical and experimental rheumatology, 2023, Volume: 41, Issue:4 Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2023
Assessing the feasibility of SUVindex (a metric derived from FDG PET/CT) for the diagnosis of polymyalgia rheumatica. Clinical radiology, 2023, Volume: 78, Issue:10 Topics: Feasibility Studies; Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2023
Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumatica. Joint bone spine, 2021, Volume: 88, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis	2021
Images in Vascular Medicine: Usefulness of carotid ultrasonography for diagnosis and management of polymyalgia rheumatica-associated large-vessel vasculitis. Vascular medicine (London, England), 2021, Volume: 26, Issue:4 Topics: Cardiology; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Ultrasonography	2021
Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis. Scientific reports, 2021, 03-18, Volume: 11, Issue:1 Topics: Adipose Tissue, White; Age Factors; Aged; Aged, 80 and over; Aorta; Biopsy; Blood Pressure; Body Composition; Bone Density; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Longitudinal Studies; Male; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisolone; Prognosis; Pulse Wave Analysis; Sex Factors; Temporal Arteries; Vascular Stiffness	2021
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica. Clinical and experimental rheumatology, 2022, Volume: 40, Issue:1 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica. Rheumatology (Oxford, England), 2022, 03-02, Volume: 61, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Retrospective Studies	2022
[18F-FDG-PET/CT AS A TOOL FOR DIAGNOSIS AND FOLLOW-UP OF INFLAMMATORY DISEASES OF LARGE BLOOD VESSELS]. Harefuah, 2021, Volume: 160, Issue:7 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2021
Early onset polymyalgia rheumatica: two rare cases under age of 50. Skeletal radiology, 2017, Volume: 46, Issue:6 Topics: Anti-Inflammatory Agents; Arthralgia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Joints; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisolone; Radiopharmaceuticals; Whole Body Imaging	2017
PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia. Danish medical journal, 2017, Volume: 64, Issue:10 Topics: Aged; Aged, 80 and over; C-Reactive Protein; Denmark; Female; Fluorodeoxyglucose F18; Hip; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Shoulder; Spine	2017
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica. Rheumatology (Oxford, England), 2018, 02-01, Volume: 57, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Hamstring Tendons; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tendinopathy; Whole Body Imaging	2018
Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica-A prospective study of 99 patients. Rheumatology (Oxford, England), 2018, 11-01, Volume: 57, Issue:11 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography; Prospective Studies	2018
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis. Annals of the rheumatic diseases, 2018, Volume: 77, Issue:11 Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prospective Studies	2018
The utility of FDG-PET in complex neurological conditions. Internal medicine journal, 2017, Volume: 47, Issue:12 Topics: Adult; Encephalitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurologic Examination; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vasculitis	2017
In search of a diagnostic test for polymyalgia rheumatica: is positron emission tomography the answer? Rheumatology (Oxford, England), 2018, 11-01, Volume: 57, Issue:11 Topics: Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Prospective Studies	2018
Response to: 'Is the PET/CT first choice for differential diagnosis of FUO/IUO?' by Armagan Annals of the rheumatic diseases, 2018, Volume: 77, Issue:11 Topics: Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prospective Studies	2018
Predictors of positive Seminars in arthritis and rheumatism, 2019, Volume: 48, Issue:4 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2019
Diagnostic FDG PET/CT findings in polymyalgia rheumatica. QJM : monthly journal of the Association of Physicians, 2019, Feb-01, Volume: 112, Issue:2 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography	2019
Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis. Rheumatology (Oxford, England), 2019, 05-01, Volume: 58, Issue:5 Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Reference Values; Retrospective Studies	2019
Positron emission tomography: the ideal tool in polymyalgia rheumatica? Joint bone spine, 2014, Volume: 81, Issue:5 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Neoplasms; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Modern rheumatology, 2015, Volume: 25, Issue:4 Topics: Aged; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Hip Joint; Humans; Male; Multimodal Imaging; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Shoulder Joint; Tomography, X-Ray Computed	2015
FDG positron emission tomography of giant cell arteritis with polymyalgia rheumatica. BMJ case reports, 2015, Mar-11, Volume: 2015 Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals	2015
Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2015, Volume: 159, Issue:4 Topics: Aged; Aged, 80 and over; Bursitis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Multimodal Imaging; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Synovitis; Vasculitis	2015
Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Rheumatology (Oxford, England), 2016, Volume: 55, Issue:8 Topics: Aged; Aged, 80 and over; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2016
Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica. Rheumatology international, 2016, Volume: 36, Issue:8 Topics: Aged; Breast Neoplasms; Cell-Derived Microparticles; Colonic Neoplasms; Female; Fibrin; Fluorodeoxyglucose F18; Humans; Middle Aged; Paraneoplastic Syndromes; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Whole Body Imaging	2016
Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR? PloS one, 2016, Volume: 11, Issue:7 Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Rheumatology; ROC Curve	2016
Involvement of pubic symphysis in polymyalgia rheumatica: 18-FDG PET/CT evaluation. Joint bone spine, 2017, Volume: 84, Issue:5 Topics: Aged; Case-Control Studies; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Pubic Symphysis; Radiographic Image Enhancement; Reference Values; Severity of Illness Index	2017
F-18 FDG PET/CT of polymyalgia rheumatica. Clinical nuclear medicine, 2009, Volume: 34, Issue:5 Topics: Aged; Cartilage; Female; Fluorodeoxyglucose F18; Humans; Joints; Muscle, Skeletal; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed	2009
[A case of polymyalgia rheumatica where a complication of large-vessel vasculitis was diagnosed by FDG-PET]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2009, Volume: 32, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography	2009
Occult Hodgkin lymphoma presenting as polymyalgia rheumatica: value of [18F]-FDG positron emission tomography. Annals of hematology, 2010, Volume: 89, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography	2010
FDG-PET/CT of polymyalgia rheumatica. Modern rheumatology, 2011, Volume: 21, Issue:3 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Synovitis; Tomography, X-Ray Computed	2011
Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Modern rheumatology, 2012, Volume: 22, Issue:5 Topics: Aged; Aged, 80 and over; Aorta; Arteries; Arthritis, Rheumatoid; Behcet Syndrome; Bursitis; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Multimodal Imaging; Polymyalgia Rheumatica; Polymyositis; Positron-Emission Tomography; Predictive Value of Tests; Still's Disease, Adult-Onset; Subclavian Artery; Tomography, X-Ray Computed; Vasculitis	2012
Polymyalgia rheumatica and interspinous FDG uptake on PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:5 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Polymyalgia Rheumatica; Positron-Emission Tomography; Spine; Tomography, X-Ray Computed	2012
Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint bone spine, 2013, Volume: 80, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Joints; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Spondylarthropathies; Tomography, X-Ray Computed	2013
Polymyalgia rheumatica and giant-cell arteritis. The New England journal of medicine, 2002, Dec-19, Volume: 347, Issue:25 Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Radiopharmaceuticals; Tomography, Emission-Computed	2002
[Lymph node tuberculosis in a patient with polymyalgic symptoms: value of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)]. Zeitschrift fur Rheumatologie, 2003, Volume: 62, Issue:3 Topics: Blood Glucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Muscle, Skeletal; Polymyalgia Rheumatica; Tomography, Emission-Computed; Tuberculosis, Lymph Node	2003
Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Annals of the rheumatic diseases, 2004, Volume: 63, Issue:7 Topics: Aged; Aorta; Arteritis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Female; Fluorodeoxyglucose F18; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Polymyalgia Rheumatica; Radiopharmaceuticals; Remission Induction; Statistics, Nonparametric; Tomography, Emission-Computed	2004
18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: novel insight into complex pathogenesis but questionable use in predicting relapses. Rheumatology (Oxford, England), 2007, Volume: 46, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence	2007
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford, England), 2007, Volume: 46, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hip; Humans; Male; Methylprednisolone; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Severity of Illness Index; Shoulder; Spine; Subclavian Artery	2007
Polymyalgia rheumatica as the manifestation of unclassified aortitis. Modern rheumatology, 2008, Volume: 18, Issue:1 Topics: Adrenal Cortex Hormones; Aortitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography; Takayasu Arteritis	2008
Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? Rheumatology (Oxford, England), 2008, Volume: 47, Issue:6 Topics: Aged; Drug Resistance; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Vasculitis	2008
F-18 FDG PET/CT in giant cell arteritis with polymyalgia rheumatica. Clinical nuclear medicine, 2008, Volume: 33, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. The American journal of medicine, 2000, Feb-15, Volume: 108, Issue:3 Topics: Aged; Aortitis; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Radiopharmaceuticals; Subclavian Artery; Tomography, Emission-Computed	2000